| PAFAH1B3在三阴性乳腺癌发生中的作用 |
| |
| 引用本文： | 褚玉新,胡钦勇,宋启斌.PAFAH1B3在三阴性乳腺癌发生中的作用[J].肿瘤学杂志,2020,26(1):22-25. |
| |
| 作者姓名： | 褚玉新 胡钦勇 宋启斌 |
| |
| 作者单位： | 武汉大学人民医院肿瘤中心,武汉大学人民医院肿瘤中心,武汉大学人民医院肿瘤中心 |
| |
| 基金项目： | 国家自然科学基金资助(81670123，81670144) |
| |
| 摘 要： | 三阴性乳腺癌有独特的临床表型,目前缺乏有效的靶向治疗药物。研究三阴性乳腺癌的发生机制,寻找新的治疗靶点迫在眉睫。PAFAH1B3是驱动三阴性乳腺癌发生中的一种关键代谢酶,靶向沉默PAFAH1B3会导致多种抑癌的信号脂类上调,抑制癌细胞的增殖和侵袭。PAFAH1B3可能成为一种新的治疗靶点,有广泛的应用前景。
|
| 关 键 词： | 三阴性乳腺癌 PAFAH1B3 靶向治疗 |
| 收稿时间： | 2019/4/8 0:00:00 |
The Role of PAFAH1B3 in Pathogenesis of Triple Negative Breast Cancer |
| |
| CHU Yu-xin,HU Qin-yong,SONG Qi-bin.The Role of PAFAH1B3 in Pathogenesis of Triple Negative Breast Cancer[J].Journal of Oncology,2020,26(1):22-25. |
| |
| Authors: | CHU Yu-xin HU Qin-yong SONG Qi-bin |
| |
| Institution: | (Cancer Center,Renmin Hospital of Wuhan university,Wuhan 430060,China) |
| |
| Abstract: | Breast cancer seriously threatens the health of women,its incidence is increasing recently.Triple negative breast cancer( TNBC) has distinct clinical phenotypes,there are no effective targeting drugs available currently. It is imperative to further study the pathogenesis of TNBC and seek novel targets for therapy. PAFAH1B3 is a critical driver of TNBC pathogenicity,targeting PAFAH1B3 can upregulate a series of anti-tumorigenic lipids,inhibiting the proliferation and invasion of cancer cells.PAFAH1B3 may be a promising target for treatment of TNBC. |
| |
| Keywords: | triple negative breast cancer PAFAH1B3 targettherapy |
| 本文献已被 维普 等数据库收录！ |
| 点击此处可从《肿瘤学杂志》浏览原始摘要信息 |
| 点击此处可从《肿瘤学杂志》下载免费的PDF全文 |
|
